Long-Term Exposure to CdTe Quantum Dots Causes Functional Impairments in Live Cells
Citations Over TimeTop 1% of 2007 papers
Abstract
Several studies suggested that the cytotoxic effects of quantum dots (QDs) may be mediated by cadmium ions (Cd2+) released from the QDs cores. The objective of this work was to assess the intracellular Cd2+ concentration in human breast cancer MCF-7 cells treated with cadmium telluride (CdTe) and core/shell cadmium selenide/zinc sulfide (CdSe/ZnS) nanoparticles capped with mercaptopropionic acid (MPA), cysteamine (Cys), or N-acetylcysteine (NAC) conjugated to cysteamine. The Cd2+ concentration determined by a Cd2+-specific cellular assay was below the assay detection limit (<5 nM) in cells treated with CdSe/ZnS QDs, while in cells incubated with CdTe QDs, it ranged from approximately 30 to 150 nM, depending on the capping molecule. A cell viability assay revealed that CdSe/ZnS QDs were nontoxic, whereas the CdTe QDs were cytotoxic. However, for the various CdTe QD samples, there was no dose-dependent correlation between cell viability and intracellular [Cd2+], implying that their cytotoxicity cannot be attributed solely to the toxic effect of free Cd2+. Confocal laser scanning microscopy of CdTe QDs-treated cells imaged with organelle-specific dyes revealed significant lysosomal damage attributable to the presence of Cd2+ and of reactive oxygen species (ROS), which can be formed via Cd2+-specific cellular pathways and/or via CdTe-triggered photoxidative processes involving singlet oxygen or electron transfer from excited QDs to oxygen. In summary, CdTe QDs induce cell death via mechanisms involving both Cd2+ and ROS accompanied by lysosomal enlargement and intracellular redistribution.
Related Papers
- → Fluorescence sensor based on d-penicillamine capped cadmium sulfide quantum dots for the detection of cysteamine(2017)22 cited
- → A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis(2021)22 cited
- → Evaluation of carbohydrate-cysteamine thiazolidines as pro-drugs for the treatment of cystinosis(2016)15 cited
- → Pantetheinase Activity and Cysteamine Content in Cystinotic and Normal Fibroblasts and Leukocytes(1981)39 cited
- → A Comparison of Immediate Release and Delayed Release Cysteamine in 17 Patients with Nephropathic Cystinosis(2021)2 cited